Hepatozelluläres Karzinom
Das hepatozelluläres Karzinom der Kindheit wird durch somatische Mutationen im MET-Gen ausgelöst.
Gliederung
Referenzen:
| 1. |
Yong KJ et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. [^] |
| 2. |
Hopkins LJ et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. [^] |
| 3. |
Suzuki E et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. [^] |
| 4. |
Masuda S et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. [^] |
| 5. |
Kishnani PS et. al. (2009) Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. [^] |
| 6. |
Napoli VM et. al. (1977) Hepatoblastoma in infant sister and brother. [^] |
| 7. |
Shen FM et. al. (1991) Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. [^] |
| 8. |
Buetow KH et. al. (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. [^] |
| 9. |
Pasquinelli C et. al. (1988) Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. [^] |
| 10. |
Henderson AS et. al. (1988) Identification of a chromosomal aberration associated with a hepatitis B DNA integration site in human cells. [^] |
| 11. |
Zhou YZ et. al. (1988) Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. [^] |
| 12. |
Blanquet V et. al. (1988) Regional mapping to 4q32.1 by in situ hybridization of a DNA domain rearranged in human liver cancer. [^] |
| 13. |
Wang HP et. al. (1988) Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. [^] |
| 14. |
Rogler CE et. al. (1985) Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. [^] |
| 15. |
Fisher JH et. al. (1987) Sequences which flank an 11p deletion observed in an hepatocellular carcinoma map to 11p13. [^] |
| 16. |
Ito E et. al. (1987) Type 1a glycogen storage disease with hepatoblastoma in siblings. [^] |
| 17. |
Hagstrom RM et. al. (1968) Primary hepatocellular carcinoma in three male siblings. [^] |
| 18. |
Fraumeni JF et. al. (1969) Hepatoblastoma in infant sisters. [^] |
| 19. |
Denison EK et. al. (1971) Familial hepatoma with hepatitis-associated antigen. [^] |
| 20. |
Lynch HT et. al. (1984) Familial hepatocellular carcinoma in an endemic area of Thailand. [^] |
| 21. |
Chang MH et. al. (1984) Fraternal hepatocellular carcinoma in young children in two families. [^] |
| 22. |
McGlynn KA et. al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. [^] |
| 23. |
Oda H et. al. (1996) Somatic mutations of the APC gene in sporadic hepatoblastomas. [^] |
| 24. |
Agarwal VR et. al. (1998) Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. [^] |
| 25. |
Schwienbacher C et. al. (2000) Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. [^] |
| 26. |
Taniguchi K et. al. (2002) Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. [^] |
| 27. |
Thorgeirsson SS et. al. (2002) Molecular pathogenesis of human hepatocellular carcinoma. [^] |
| 28. |
Ye QH et. al. (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. [^] |
| 29. |
Shin HD et. al. (2003) Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. [^] |
| 30. |
KAPLAN L et. al. (1965) FRATERNAL PRIMARY HEPATOCELLULAR CARCINOMA IN THREE MALE, ADULT SIBLINGS. [^] |
| 31. |
Lee JW et. al. (2005) PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. [^] |
| 32. |
Chiu CM et. al. (2007) Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. [^] |
| 33. |
Tanabe KK et. al. (2008) Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. [^] |
| 34. |
Yoo BK et. al. (2009) Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. [^] |
| 35. |
Hill-Baskin AE et. al. (2009) Diet-induced hepatocellular carcinoma in genetically predisposed mice. [^] |
| 36. |
Yoo BK et. al. (2009) Identification of genes conferring resistance to 5-fluorouracil. [^] |
| 37. |
Ji J et. al. (2009) MicroRNA expression, survival, and response to interferon in liver cancer. [^] |
| 38. |
Zhang H et. al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. [^] |
| 39. |
Kumar V et. al. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. [^] |
| 40. |
Li M et. al. (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. [^] |
| 41. |
Huang J et. al. (2012) Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. [^] |
| 42. |
Honeyman JN et. al. (2014) Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. [^] |
